Scientists Reveal New Targets For Anti-Angiogenesis Drugs

A new study describes how a carbohydrate-binding protein, galectin-3, promotes angiogenesis, the growth of new blood vessels. Targeting the protein, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries, published online August 16 in The Journal of Experimental Medicine, may lead to novel treatments for diseases caused by excessive angiogenesis …

This entry was posted in Preventative Medicine. Bookmark the permalink.

Comments are closed.